Devonian Health Group Inc.
Devonian Health Group Inc. (DVHGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DVHGF · as of Jun 9, 2026
Key Statistics
Explore Devonian Health Group Inc. Data
dvhgf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dvhgf competitorsDVHGF
ECGS
HMTXF
HOOK
IMUC
INTIStock Performance
Full HistoryAbout Devonian Health Group Inc.
Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat con…
what is devonian health group inc. · dvhgf stock overview · devonian health group inc. company profile · who is devonian health group inc. ceo · dvhgf OTC · devonian health group inc. headquarters · devonian health group inc. business segments
About Stock Overview & Key Data
Devonian Health Group Inc. (DVHGF) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 19, 2022. As of the latest trading session, DVHGF stock price is $10.65, with a market capitalization of $29.6M. The stock has returned -1.39% over the past 12 months and +149.41% year-to-date.
In fiscal year 2025, Devonian Health Group Inc. reported revenue of $17.0M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Devonian Health Group Inc. (DVHGF) stock price is $10.65. The stock is traded on OTC under the ticker symbol DVHGF. The 52-week range is $4.27 – $10.80.